Dexoligo Therapeutics
- Biotech or pharma, therapeutic R&D
Dexoligo Therapeutics is a preclinical-stage company dedicated to the development of first-in-class siRNA therapeutics. Dexoligo was founded in 2021 by a team with extensive experience and expertise in the development of RNA therapeutics. The company is actively building out a pipeline of liver-targeted GalNAc siRNA programs across a range of therapeutic areas, while simultaneously advancing novel delivery platforms.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}